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The clinical manifestations of Lonomia obliqua caterpillar envenomation are systemic
hemorrhage and acute kidney injury. In an effort to better understand the physiopatho-
logical mechanisms of envenomation, a rat model was established to study systemic tissue
damage during L. obliqua envenomation. An array of acute venom effects was characterized,
including biochemical, hematological, histopathological, myotoxic and genotoxic alter-
ations. Rapid increases in serum alanine and aspartate transaminases, g-glutamyl trans-
ferase, lactate dehydrogenase, hemoglobin, bilirubin, creatinine, urea and uric acid were
observed, indicating that intravascularhemolysis and liver and kidneydamagehad occurred.
Treatmentwith a speciﬁc antivenom (antilonomic serum) for up to 2 h post-venom injection
neutralized the biochemical alterations. However, treatment after 6 h post-venom injection
failed to normalize all biochemical parameters, despite its efﬁcacy in reversing coagulation
dysfunction. The hematological ﬁndings were consistent with hemolytic anemia and
neutrophilic leukocytosis. The histopathological alterations were mainly related to hemor-
rhage and inﬂammation in the subcutaneous tissue, lung, heart and kidneys. Signs of
congestion and hemosiderosis were evident in the spleen, and hemoglobin and/or
myoglobin casts were also detected in the renal tubules. Increased levels of creatine kinase
and creatine kinase-MB were correlated with the myocardial necrosis observed in vivo and
conﬁrmed the myotoxicity detected in vitro in isolated extensor digitorum longus muscles.
Signiﬁcant DNAdamagewas observed in the kidneys, heart, lung, liver and lymphocytes. The
majority of the DNA lesions in the kidney were due to oxidative damage. The results pre-
sented here will aid in understanding the pathology underlying Lonomia’s envenomation.
 2013 Elsevier Ltd. All rights reserved.ax: þ55 51 33087309.
arães).
. All rights reserved.
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damage and its management (Gamborgi et al., 2006).Contact dermatitis and urticarial cutaneous reactions
are well known signs of accidental contact with the hairs
and spines of many lepidopterous larvae (Hossler, 2010).
The consequences of these reactions are usually limited to
local skin inﬂammation without any systemic tissue dam-
age. However, contact with Lonomia spp. has been associ-
ated with potentially fatal systemic disorders, such as
hemorrhage and acute kidney injury (AKI) (Arocha-
Piñango et al., 2000; Pinto et al., 2010). One of these spe-
cies is the moth Lonomia obliqua (Lepidoptera, Saturniidae),
which is highly venomous in the larval stages. Larval forms
occur during spring and summer in the southern regions of
Brazil (mainly in the states of Rio Grande do Sul, Santa
Catarina and Paraná) where envenomation by this animal is
an important public health problem due to its high inci-
dence (Veiga et al., 2009; Pinto et al., 2010; Guimarães,
2011). In fact, this caterpillar is responsible for severe and
sometimes fatal accidents caused by skin contact with the
bristles that cover the animal’s body. Unlike snakes, spiders
and scorpions, there is no specialized venomous gland in L.
obliqua. The venom is produced by secretory epithelial cells
of the tegument and stored in a hollow internal channel in
each bristle. Because the bristles have weak articulations at
their tips, only a slight contact with the skin is enough to
break off these chitinous structures, injecting the venom
into the subcutaneous tissue of victims (Veiga et al., 2001).
Furthermore, accidents frequently involve colonies of
dozens or hundreds of caterpillars that are camouﬂaged at
tree trunks, which makes accidental contact more
dangerous due to the venom quantities absorbed by the
victim.
Clinical symptoms include local pain (burning sensa-
tion) and an inﬂammatory reaction, which starts immedi-
ately after contact, followed by systemic reactions,
including headache, fever, vomiting and hypotension. Signs
of bleeding diathesis, characterized by hematomas, ecchy-
mosis, gross hematuria, hematemesis and melena are
frequently observed between 6 and 72 h after contact. If the
victim is not promptly treated, the clinical proﬁle can
evolve to intracerebral hemorrhage, AKI and death (Zannin
et al., 2003; Kowacs et al., 2006; Garcia and Danni-Oliveira,
2007). Actually, the unique speciﬁc treatment available for
L. obliqua envenomation is the early intravenous adminis-
tration of anti-lonomic serum (ALS), an animal-derived
antivenom. ALS is a concentrated pool of immunoglobu-
lins (usually pepsin-reﬁned F(ab0)2 fragments of whole IgG)
that is puriﬁed from the plasma of a horse that has been
immunized with the venom (obtained from bristle ho-
mogenates) (Rocha-Campos et al., 2001). In Brazil, ALS is
produced by the Butantan Institute (São Paulo) and has
been successfully used to re-establish physiological coag-
ulation parameters in envenomed patients and experi-
mental models (Caovilla and Barros, 2004). Despite its
clinical efﬁcacy, the prompt availability of ALS and a correct
medical diagnosis in the regions of high incidence of acci-
dents still remain public health concerns, namely, in rural
areas of Southern Brazil. Another important problem is the
fact that administration of ALS does not decrease the inci-
dence of AKI, which is likely also related to the lack ofRecently, molecular biology and proteomic studies have
contributed to the increasing number of toxins that have
been identiﬁed in L. obliqua venomous secretions,
providing valuable information regarding how this toxin
cocktail acts on biological tissues (Veiga et al., 2005; Ricci-
Silva et al., 2008). Toxins related to envenomation symp-
tomatology, especially those that cause hemostatic distur-
bances, such as serine proteases, phospholipases A2, lectins
and protease inhibitors, were identiﬁed. These toxins are
able to directly modulate the victim’s hemostatic system by
proteolytic activation of the coagulation and ﬁbrinolytic
cascades, generating high concentrations of intravascular
thrombin, plasmin, urokinase and kallikrein (Reis et al.,
2006; Pinto et al., 2008; Berger et al., 2010a). As a conse-
quence, consumption coagulopathy with decreased levels
of ﬁbrinogen, factors V and XIII, pre-kallikrein, plasmin-
ogen, protein C and a2-antiplasmin occurs (Zannin et al.,
2003). Platelet aggregation function is also markedly
impaired during envenomation, which contributes signiﬁ-
cantly to the bleeding disorders (Berger et al., 2010a,b).
Moreover, the venom also triggers an acute inﬂammatory
response and disturbances in the vascular system, inducing
increases in blood–brain barrier permeability, hypotension
and the nociceptive and edematogenic responses (Da Silva
et al., 2004a; De Castro Bastos et al., 2004; Bohrer et al.,
2007; Nascimento-Silva et al., 2012).
Despite understanding the mechanisms involved in the
hemorrhagic syndrome, little is known about the systemic
physiopathological effects induced by L. obliqua venom.
Although venomcomponents have been detected in several
organs (including the kidneys, lungs, liver, spleen, heart and
skeletal muscle) of rats following a single subcutaneous
injection of the venom, the systemic tissue damage in these
organs remains poorly characterized (Rocha-Campos et al.,
2001; Da Silva et al., 2004b). For example, the current level
of knowledge regarding the kidney damage is based only on
a few clinical case reports in which hematuria and high
levels of serumcreatinine aredescribed as themain features
of L. obliqua-induced AKI (Burdmann et al., 1996). The
venom-induced pathology in other organs remains
completely unknown. In human patients, the impossibility
of conducting early tissue biopsies, due to the coagulation
disturbances inherent to the envenomation, has made it
difﬁcult to analyze the acute anatomopathological alter-
ations. For these reasons, we believe that animal models of
envenomation may be useful not only to characterize the
underlying physiopathology but also to identify previously
unknown toxic activities of the venom. Therefore, the aimof
the present work was to develop a rat model to study sys-
temic tissue damage during L. obliqua envenomation. An
array of acute effects of the venom was characterized,
including biochemical, hematological, histopathological,
myotoxic and genotoxic alterations.
In summary, our data indicate that in addition to hemo-
static abnormalities, there are also signs of multi-organ
damage, mainly in the lungs, heart, kidneys and spleen.
Treatment with ALS is only effective at counteracting the
systemic physiopathological effects if it is administered dur-
ing the initial phase of envenomation. In addition, this study
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myotoxic and genotoxic activities of L. obliqua venom.
2. Materials and methods
2.1. Venom extraction and antivenom
L. obliqua caterpillars were kindly provided by the
Centro de Informações Toxicológicas (CIT), Porto Alegre, Rio
Grande do Sul, Brazil. The specimens used in this study
were collected in the cities of Bom Princípio (Rio Grande do
Sul, Brazil) and Videira (Santa Catarina, Brazil). L. obliqua
venom was obtained by cutting the bristles at the cater-
pillar’s tegument insertion, and the excised material was
kept at 4 C prior to the preparation of the extract, which
occurred immediately after dissection. The bristles were
macerated in cold phosphate-buffered saline (PBS),
pH ¼ 7.4, and centrifuged at 9600  g for 20 min. The su-
pernatant, designated Lonomia obliqua Bristle Extract
(LOBE), was used as the venomous secretion in all experi-
ments. The protein content of the LOBE samples was
determined using a BCA assay kit (Pierce, Rockford, Illinois,
USA) and the aliquots were stored at 80 C prior to use.
The total number of caterpillars used for bristle extract
preparation was 187 specimens and the protein concen-
tration of the LOBE samples was 3.83 mg/mL. The total
amount of venom extracted per caterpillar was 1.2 mg. All
of the LOBE samples had similar in vitro pro-coagulant ac-
tivities and the protein compositions were also similar, as
monitored by electrophoresis and gel ﬁltration chroma-
tography (Pinto et al., 2006; Berger et al., 2010a,b).
L. obliqua antivenom (antilonomic serum – ALS) was
provided by the Butantan Institute (São Paulo, Brazil). Each
ampoule of ALS (10 mL/vial) is able to neutralize 3.5 mg of
the LOBE. The ALS used here is the same one distributed to
hospitals to treat envenomed patients.
2.2. Animals and ethical statements
Adult male Wistar rats, weighing 250–300 g, were
supplied by the Central Animal Facility (CREAL), Institute of
Basic Health Sciences, Federal University of Rio Grande do
Sul, Brazil. They were housed in plastic cages (5 animals per
cage) within a temperature controlled room (22–23 C, on a
12 h light/dark cycle, with the lights on at 7:00 am) and had
free access to water and food. All procedures involving
animals were carried out in accordance with the Guiding
Principles for the Use of Animals in Toxicology (Interna-
tional Society of Toxicology, http://www.toxicology.org)
and the Brazilian College of Animal Experimentation
(COBEA). The experimental protocol was approved by the
ethical committee on research animal care of the Federal
University of Rio Grande do Sul, Brazil (register number
2008177/2009).
2.3. Experimental design
2.3.1. Venom treatment
To follow the time course of physiopathological alter-
ations, we developed an experimental model of enven-
omation in rats. The animals were divided into two groups:(i) Control group (CTRL) – Animals (n¼ 6 per sampling time)
were injected subcutaneously (s.c.) with 100 mL of sterile
PBS solution. (ii) Experimental group (LOBE) – Animals
(n ¼ 8 per sampling time) were injected s.c. with a solution
containing 1.0 mg of the LOBE per kg of body weight in a
ﬁnal volume of 100 mL. At several time points post-venom
injection (2, 6, 12, 24, 48 and 96 h), blood and various or-
gans were collected for biochemical, hematological and
histopathological analysis. This venom dose was selected
based on the results of our previous experiments using rats
as an animal model (Berger et al., 2010a) and was also
based on other studies that have used similar doses to
reproduce the consumption coagulopathy observed in
humans (Dias da Silva et al., 1996; Rocha-Campos et al.,
2001).
2.3.2. Antivenom treatment
The neutralizing ability of the antivenom was tested
using the experimental model of envenomation. Rats that
had previously been injected with the LOBE (1.0 mg/kg, s.c.)
were treated 2 or 6 h after venom injection. At these time
intervals, the animals (n ¼ 8/group) were intravenously
(i.v.) administered through the caudal vein with a sterile
PBS solution (1 mL/100 g of body weight) or ALS (1 mL/
100 g of body weight). Additional control groups (n ¼ 6/
group) were injected only with PBS or ALS under the same
conditions. At 24 h after the treatments, blood was
collected to measure biochemical and hematological
markers of tissue damage. The dose of ALS used here is
sufﬁcient to completely neutralize the in vitro pro-
coagulant activity of the LOBE. Moreover, the same dose
was used in a previous study to compare the efﬁcacy be-
tween ALS and antiﬁbrinolytic drugs (Gonçalves et al.,
2007).
2.4. Blood samples
After treatment, animals from the different groups were
anesthetized intraperitoneally (i.p.) with a mixture of ke-
tamine (75 mg/kg) (Syntec, São Paulo, Brazil) and xylazine
(10 mg/kg) (Syntec, São Paulo, Brazil), and blood was
collected by cardiac puncture. For the coagulation and he-
matological assays, the blood samples were collected in
1:10 (v/v) 3.8% trisodium citrate (Merck, Darmstadt, Ger-
many) or 1:16 (v/v) 10% Na2-EDTA (Merck, Darmstadt,
Germany), respectively, while for the biochemical assays,
no anticoagulants were used. All samples had 2% (v/v) ALS
added to block the activity of the toxin after blood collec-
tion. Plasma and serum were obtained by centrifugation at
1500  g for 10 min and stored at 80 C prior to use.
2.5. Biochemical parameters
Serum samples were used to measure several
biochemical markers of tissue injury. Blood urea nitrogen
(BUN), creatinine (Cr), uric acid (UA), creatine kinase (CK),
creatine kinase – MB fraction (CK-MB), aspartate amino-
transferase (AST), alanine aminotransferase (ALT), g-glu-
tamyl transferase (g-GT), lactate dehydrogenase (LDH),
plasma free hemoglobin (Hb) and bilirubin (BIL) levels
were determined using commercially available kits
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manufacturer’s recommended instructions. The absor-
bance was read using a SP-220 spectrophotometer (Bio-
Spectro, Paraná, Brazil), or the protocol was adapted for use
in 96-well plates and the reads were performed using a
SpectraMAX microplate reader (Molecular Devices Co.,
Sunnyvale, USA). Free hemoglobin (Hb) was measured in
the plasma samples that had been collected with Na2-
EDTA. In these cases, plasma Hb levels were determined
directly by spectrophotometry using a standard curve
made with known concentrations of puriﬁed Hb (Sigma–
Aldrich, Saint Louis, MO, USA). Samples with levels of free
Hb higher than 180 mg/dL due to LOBE-induced intravas-
cular hemolysis were diluted to avoid interference during
the determination of other parameters.
2.6. Hematological parameters
Complete blood cell counts were carried out on plasma
samples containing the anticoagulant Na2-EDTA. Hemo-
globin concentration (Hb), hematocrit (Hct), red blood cell
counts (RBC), white blood cell counts (WBC) and the
hematimetric indices (mean corpuscular volume [MCV],
mean corpuscular hemoglobin [MCH] and mean corpus-
cular hemoglobin concentration [MCHC]) were determined
using an automated cell counter (ABX Micros ESV 60,
Horiba, São Paulo, Brazil). Platelet counts (PLT) were per-
formed using a hemocytometer (Neubauer chamber) with
10% ammonium oxalate (Merck, Darmstadt, Germany) as
diluent. Blood smears stained with May-Grünwald Giemsa
(BioClin/Quibasa, Belo Horizonte, Brazil) were prepared for
direct examination of red blood cell morphology, platelet
morphology and leukocyte differential counts under light
microscopy. Reticulocyte counts (Retic) were also deter-
mined in blood smears with Brilliant Cresyl Blue (Laborclin,
Paraná, Brazil) staining immediately after blood collection.
Retic values were expressed as the % of total RBC counts.
Blood coagulation parameters (activated partial thrombo-
plastin time [aPTT] and ﬁbrinogen concentration [FBG])
were measured in plasma that had been collected with
trisodium citrate by following a previously described pro-
tocol (Berger et al., 2010a).
2.7. Histopathological analyses
All animals from the control and envenomed groups (at
each sampling time) were necropsied and gross macro-
scopic alterations were examined. The kidneys, spleen,
liver, heart, lungs, brain, cerebellum and skin (at the site of
venom injection) were then carefully removed and ﬁxed in
a 10% neutral buffered formaldehyde solution. The tissues
were dehydrated in gradual alcohol from 50% to 100%,
cleared in xylene and embedded in parafﬁn. Subsequently,
the samples were sectioned and stained with hematoxylin
and eosin (H&E) for further analysis by light microscopy.
2.8. In vitro myotoxic activity
The in vitro myotoxic activity assays were performed as
previously described (Melo and Suarez-Kurtz, 1988; Fuly
et al., 2003). Brieﬂy, rats were anesthetized (as describedabove) and the extensor digitorum longus (EDL) muscles
were carefully dissected, weighed and transferred to a bath
chamber with a 2.5 mL capacity. The muscles were super-
fused continuously with a physiological solution (135 mM
NaCl; 5 mM KCl, 2 mM CaCl2; 1 mMMgCl2; 1 mM NaHPO4;
15 mM NaHCO3 and 11 mM dextrose, pH ¼ 7.35) that was
equilibrated with 95% O2/5% CO2. During superfusion,
different concentrations of the LOBE (40 and 80 mg/mL), or
the LOBE (40 mg/mL) that had been previously incubated
with ALS (800 mL), were added to the bath. Bothrops jar-
araca snake venom (Butantan Institute, São Paulo, Brazil),
and Triton X-100 (Sigma–Aldrich, Saint Louis, MO, USA)
were used as positive controls for muscle damage under
the same conditions. Preincubation of the venom with
antivenom was performed at room temperature 30 min
prior to addition to the perfusion bath. Samples of the
perfusate (0.4 mL) were collected at 30 min intervals over a
total period of 120 min and replaced with fresh solution.
The collected samples were stored at 4 C and their creatine
kinase (CK) activity was determined according to the pro-
cedure described above (Subsection 2.5). EDL preparations
were mounted in the bath chambers for a period of 60 min
prior to the experiment for measurements of basal CK
release rates, which were deﬁned as the amount of enzyme
released from the muscles into the perfusion bath prior to
the addition of venom. The increase in CK released from
EDL muscles after addition of LOBE was considered to be
indicative of direct myotoxic activity. CK activity was
expressed as enzyme units released into the medium per
gram of muscle (U/g). One enzyme unit was deﬁned as the
amount that catalyzes the transformation of 1 mmol of
substrate per min at 25 C.
2.9. Determination of DNA damage and oxidized bases
2.9.1. Sample preparation
The genotoxic activity was detected in vivo using the
model of envenomation described in Subsection 2.3.1. The
blood, liver, lungs, heart and kidneys were collected at 6, 12
and 48 h after LOBE injection (1 mg/kg, s.c.). The organs
were gently homogenized in a cold PBS solution (2 mL) to
obtain a cell suspension. Total blood was used for the
detection of DNAdamage in lymphocytes. Genotoxicity was
then evaluated using the comet assay.
2.9.2. Comet assay
The alkaline comet assay was performed as described by
Singh et al. (1988), with minor modiﬁcations (Azqueta
et al., 2009; Tice et al., 2000). Brieﬂy, 20 mL of homoge-
nized organs and blood were mixed with 0.75% low-
melting point agarose and immediately spread onto a
glass microscope slide that had been pre-coated with a
layer of 1% normal-melting point agarose. The slides were
then incubated in an ice-cold lysis solution (2.5 M NaCl,
10 mM Tris, 100 mM EDTA, 1% Triton X-100 and 10% DMSO,
pH ¼ 10.0; Gibco BRL, Grand Island, NY) at 4 C for at least
1 h to remove the cellular proteins andmembranes, leaving
the DNA as “nucleoids”. In the modiﬁed version of comet
assay, the slides were removed from the lysis solution and
washed three times in enzyme buffer (40 mM HEPES,
100 mM KCl, 0.5 mM Na2-EDTA, and 0.2 mg/mL BSA,
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buffer with one of the following: 70 mL of Fpg (New England
Biolabs, Beverly, MA, USA) at 100 mU per gel for 45min (for
the detection of oxidized purines) or 70 mL of Endo III (New
England Biolabs, Beverly, MA, USA) at 100 mU per gel for
30 min (for the detection of oxidized pyrimidines). After
lysis, the slides were placed in a horizontal electrophoresis
unit that had been ﬁlled with fresh buffer (300 mM NaOH
and 1 mM EDTA, pH > 13.0), which was left to cover the
slides for 20 min at 4 C to allow the DNA to unwind and
reveal the expression of alkali-labile sites. Electrophoresis
was conducted for 20 min at 25 V (78 V/cm) and 300 mA.
All of the steps outlined above were performed under
yellow light or in the dark to prevent additional DNA
damage. The slides were then neutralized (0.4 M Tris,
pH ¼ 7.5), washed in double-distilled water and stained
using a silver staining protocol, as described by Nadin et al.
(2001). After the staining step, the gels were left to dry at
room temperature overnight and were analyzed using an
optical microscope. To ensure adequate electrophoresis
conditions and efﬁciency, negative and positive internal
controls (human blood with and without 40 mM methyl
methanesulfonate [MMS, Sigma–Aldrich, Saint Louis, MO,
USA] treatment) were included in each experiment. Test
slides were scored only when the internal controls showed
clearly positive or negative results (Greggio et al., 2009).
One hundred cells (50 cells from each of two replicate
slides of each organ) were selected and analyzed for DNA
migration. When selecting the cells, cells around the edges
or air bubbles were excluded (Azqueta et al., 2009). The
cells were scored visually into ﬁve classes according to tail
length: class 0: undamaged, without a tail; class 1: with a
tail shorter than the diameter of the head (nucleus); class 2:
with a tail length 1–2 times the diameter of the head; class
3: with a tail longer than 2 times the diameter of the head;
and class 4: comets with no heads. International guidelines
and recommendations for the comet assay consider visual
scoring of the comets to be a well-validated evaluation
method (Burlinson et al., 2007). The genotoxic effects were
estimated based on two different parameters: damage
index (DI) and damage frequency (DF). The damage index
ranged from 0 (completely undamaged: 100 cells  0) to
400 (with maximum damage: 100 cells  4). The damage
frequency (%) was calculated based on the number of cells
with tails compared to the number of cells with no tails.
Levels of Endo III and Fpg-sensitive sites were calculated
from the DI score obtained with enzyme treatment minus
the score without enzyme treatment (buffered). The
vehicle was used as a negative control, and treatment with
4  105 M MMS for 1 h was used as a positive control.
2.10. Statistical analyses
Statistical analyses were performed using GraphPad
Prism 5.0 (GraphPad Software Inc., San Diego, CA, USA). The
results were expressed as the means  standard error (SE).
All biochemical and coagulationparametersweremeasured
in triplicate. The signiﬁcant differences between the mean
values of two experimental groups were determined using
the Student’s t test. When more than two groups were
compared, an analysis of variance was used, followed byBonferroni’s post-hoc test to compare pairs of means. P
values less than 0.05 were chosen to establish signiﬁcance.
3. Results
3.1. Clinical features and post mortem ﬁndings
Between 2 and 6 h after LOBE administration (1 mg/kg,
s.c.), the rats presented signs of acute toxicity, including
progressive malaise, lethargy, dyspnea, tachycardia, pros-
tration and high sensitivity at the venom injection site.
Despite general weakness, the animals showed no clear
signs of neuromuscular toxicity, such as muscle trembling,
paralysis or convulsions. Most of the envenomed animals
displayed hematuria (dark-brown urine at 6–12 h), but no
signs of macroscopic skin hemorrhage, petechiae, ecchy-
mosis, suffusions or nasal and eye bleeding were observed.
After 48 h, all of the rats had gradually recovered from the
clinical symptoms and returned to normal. Until the end of
the experiments (96 h), no deaths were registered. The
animals in the control group (injected s.c. with PBS solu-
tion) exhibited no ill effects.
Post-mortem examinations showed evidence of sys-
temic effects of the venom. During the ﬁrst 12 h period, the
animals displayed blood in the abdominal cavity, signs of
lung hemorrhage (hemorrhagic spots), spleen and kidney
enlargement and congestion (Fig. 1). The kidneys also
seemed to have darkened slightly and had black spots on
their surface (Fig. 1). The bladder was often edematous and
enlarged. The brain and gastrointestinal system appeared
to be macroscopically normal (not shown).
3.2. Biochemical and hematological parameters
To evaluate the acute systemic physiopathological ef-
fects of the venom, several biochemical and hematological
markers of tissue lesions were measured (Table 1). Subcu-
taneous injection of L. obliqua venom caused a marked in-
crease in serum AST, peaking between 12 and 48 h.
Although less markedly than AST, serum ALT also increased
rapidly after the ﬁrst 2 h, reaching a maximum at 12 h.
Serum levels of g-GT increased over the ﬁrst 6 h and
remained elevated until 48 h. In comparison to the controls,
high levels of plasma free hemoglobin, LDH and bilirubin
were detected at 6 and 12 h, indicating that intravascular
hemolysis had occurred. Markers of renal damage, such as
creatinine, BUN and uric acid, also displayed important
alterations. Serum creatinine increased mainly between 6
and 96 h, reaching maximal values at 48 h, whereas BUN
increased 12, 24 and 48 h after venom injection, returning
to normal levels thereafter. The animals had hyperuricemia
throughout the time of envenomation, with the levels of
uric acid reaching 8 times the control values (p < 0.001)
(Table 1).
Hematological parameters were evaluated at 6, 12 and
48 h post-envenomation. The obtained results are sum-
marized in Table 2. LOBE injection caused a statistically
signiﬁcant decrease in red blood cell count and hemoglobin
at 12 and 48 h, whereas the platelet count decreased
slightly at 12 h and returned to normal after 48 h. Hemat-
ocrit values were lower when compared to the controls at
Fig. 1. Macroscopic organ alterations after L. obliqua envenomation in rats.
Representative images of: A. The lungs from a control animal (one that had
been injected with PBS solution, s.c.), showing normal morphology. B. Lungs
from an animal that had been injected with LOBE (1 mg/kg, s.c.) after 6 h of
envenomation, showing signs of petechial hemorrhage (arrowheads). C.
Abdominal cavity of a control animal with normal appearance. D. Abdominal
cavity of an animal 12 h post-envenomation, evidencing the occurrence of
bleeding. Also note the kidneys, which appear to be slightly darkened and
have black spots on their surface.
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(immature red cells) increased in the blood stream as a
result of hemolysis and anemia. The hematimetric indices,
MCV and MCH, also increased at 48 h, whereas MCHC and
total protein remained unchanged. Envenomed rats dis-
played leukocytosis between 6 and 12 h, mainly due to high
neutrophil (6–48 h) and lymphocyte (6–12 h) counts.
Compared to control values, a 15-fold increase was
observed only in neutrophil numbers at 6 h. A less
expressive increase in monocytes and eosinophil counts
was also observed at the same time. Under light micro-
scopy, the blood smears revealed fragmented erythrocytes,
spherocytes and signiﬁcant anisocytosis. The leukocytes
appeared to have normal morphology (data not shown).Table 1
Biochemical markers of tissue injury during the time course of L. obliqua enveno
Parameter Time after envenomation (h)
CTRL 2 6
AST (U/mL) 11.8  0.2 32.3  0.4 30.7  2.6
ALT (U/mL) 22.4  0.6 51.9  0.9a 43.9  3.5a
g-GT (U/L) 9.2  0.6 14.1  0.9 23.4  1.4b
Hb (mg/dL) 57.7  4.6 131.1  4.4 399.9  62.5a
LDH (U/L) 431.8  40 2288  167 7374  882a
BIL-T (mg/dL) 0.2  0.08 0.6  0.07 1.8  0.2a
BIL-D (mg/dL) 0.07  0.03 0.4  0.06 0.9  0.08a
BIL-I (mg/dL) 0.1  0.05 0.2  0.01 0.9  0.09a
Cr (mg/dL) 0.30.03 0.7  0.1 1.4  0.3c
BUN (mg/dL) 43.3  0.6 53.8  1.6 74.5  2.3
UA (mg/dL) 0.6  0.04 1.6  0.06c 1.8  0.1b
CTRL: control (animals injected with PBS); AST: aspartate aminotransferase; A
hemoglobin; LDH: lactate dehydrogenase; BIL-T: total bilirubin; BIL-D: direct bi
UA: uric acid. Data are presented as means  SE of 6 animals (controls) and 8 a
c(p < 0.05) were considered statistically different when compared to the basal l3.3. Histopathological alterations
Evidence of tissue damage was observed mainly be-
tween 6 and 48 h of envenomation. Skin microscopy, at the
site of LOBE injection, showed hemorrhagic lesions, muscle
necrosis and focal inﬂammatory inﬁltration that was
associated with edema of varying intensities (Fig. 2A and
B). At 6 h, the kidneys displayed red-brown and hyaline
pigments, which formed intra-tubular cylinders and/or
accumulated within the tubular epithelial cells (Fig. 2C and
insert in 2D). At 48 h, an inﬂammatory inﬁltrate was
observed in the medullar region of the kidneys (Fig. 2D).
Marked diffuse congestion and erythrophagocytosis were
observed in the spleens at 6 h, whereas large aggregates of
hemosiderin engulfed macrophages were noted at 48 h
(Fig. 2E and F). The lungs displayed intense hemorrhaging,
which was evidenced by the presence of abundant eryth-
rocytes in the bronchiolar and alveolar spaces mainly at 6 h.
Lung sections also demonstrated mixed inﬂammatory
inﬁltrate of polymorphonuclear andmononuclear cells that
dilated the alveolar septa (48 h), edema in the pulmonary
parenchyma and perivascular edema (12 h) (Fig. 3). No
morphological changes were observed in the liver, brain
and cerebellum at any of the time points evaluated. After
96 h of envenomation, all organs displayed normal
morphology. The animals in the control group (those that
had been injected with PBS) exhibited no alterations at all.
3.4. Myotoxicity
The myotoxicity of L. obliqua venomwas evaluated both
in vivo (Fig. 4) and in vitro (Fig. 5) by measuring the release
of creatine-kinase (CK) and its cardiac isoform, creatine-
kinase-MB (CK-MB), and was also evaluated by morpho-
logical examination. After subcutaneous injection of LOBE
(1mg/kg), the rats displayed high levels of serum CK, which
was the ﬁrst evidence of skeletal muscle damage. At 12 h,
serum CK activity had increased 20-fold, reaching levels 40
times higher than control values at 48 h (Fig. 4A). Therewas
also a signiﬁcant increase in serum CK-MB activity, which
reached amaximum at 12 h (53.6 7.5 U/L) as compared to
the control group (5.8  0.4 U/L), indicating that cardiacmation in rats.
12 24 48 96
119.1  15.2a 113.5  6.8a 139.5  12.3a 17.9  1.4
69.8  3.9a 67.3  3.3a 49.2  2.4a 29.9  1.2
30.6  2.0a 36.6  3.5a 38.9  3.0a 15.8  1.7
300.7  8.9b 135.5  42.0 47.1  15.4 44.1  11.6
8578  1484a 1484  216 928.8  55 735.2  123
1.7  0.2a 0.8  0.05 0.2  0.08 0.3  0.07
1.0  0.1a 0.5  0.04 0.07  0.03 0.06  0.01
0.7  0.09a 0.3  0.03 0.1  0.05 0.2  0.01
2.5  0.4a 2.3  0.1a 3.5  0.3a 1.3  0.1c
104.7  6.3a 193.8  9.6a 211.0  9.5a 50.5  0.9
3.0  0.1a 3.6  0.2a 4.8  0.2a 3.8  0.3a
LT: alanine aminotransferase; g-GT: g-glutamyl transferase; Hb: plasma
lirubin; BIL-I: indirect bilirubin; Cr: creatinine; BUN: blood urea nitrogen;
nimals (LOBE, 1 mg/kg, via s.c). Values of a(p < 0.0001), b(p < 0.001) and
evels of control rats (ANOVA followed by Bonferroni’s post hoc test).
Table 2
Hematological parameters during the time course of L. obliqua envenomation in rats.
Parameters Time after envenomation (h)
CTRL 6 12 48
Erythrocytes
RBC (1012/L) 8.6  0.01 7.9  0.1 7.2  0.3b 4.4  0.3a
Retic (%) 1.7  0.2 2.8  0.1 9.4  0.9a 14.7  1.1a
PLT (103/mL) 465.7  43.1 349.8  16.1 316.3  44.7c 506.6  34.3
Hb (g/dL) 15.6  0.07 14.5  0.2 13.8  0.1b 10  0.6a
Hct (%) 48.5  0.7 43  0.7c 41  0.4a 32  1.7a
MCV (fL) 57.7  0.3 56.5  0.03 57  2.1 72.1  1.1a
MCH (pg) 18.2  0.1 18.2  0.01 19.3  0.7 23.5  0.2a
MCHC (g/dL) 31.9  0.3 32.9  0.4 33.7  0.1 31.2  0.3
TP (mg/dL) 67  3.1 66.5  1.5 71  1.1 71  1.2
Leukocytes
WBC (109/L) 3.8  0.08 16.5  1.3a 14.1  0.5a 5.6  0.5
Lymph (109/L) 2.5  0.1 4.6  0.3a 7.5  0.3a 2.4  0.1
Neut (109/L) 0.8  0.1 11.9  0.5a 5.3  0.3a 2.8  0.4b
Mono (109/L) 0.2  0.04 0.7  0.07c 1.3  0.1a 0.3  0.04
Eosino (109/L) 0.01  0.001 0.2  0.04c 0.1  0.03 0.02  0.001
Baso (109/L) 0.03  0.009 0.02  0.008 0.02  0.007 0.02  0.008
CTRL: control (animals injected with PBS); RBC: red blood cells; Retic: reticulocytes; PLT: platelets; Hb: hemoglobin; Hct: hematocrit; MCV: mean corpuscular
volume; MCH: mean corpuscular haemoglobin; MCHC: mean corpuscular haemoglobin concentration; TP: total protein; WBC: white blood cells; Lymph:
lymphocytes; Neut: neutrophils; Mono: monocytes; Eosino: eosinophils; Baso: basophils. Data are presented as means  SE of 6 animals (controls) and 8
animals (LOBE, 1mg/kg, via s.c). Values of a (p< 0.0001), b (p< 0.001) and c (p< 0.05) were considered statistically different when compared to the basal levels
of control rats (ANOVA followed by Bonferroni post hoc test).
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24 h (45.6  3.4 U/L) and 48 h (40.0  0.9 U/L) (Fig. 4B).
Heart histopathological analyses conﬁrmed the cardiotox-
icity of the venom. Necrosis of cardiomyocytes was asso-
ciated with inﬂammation and myocardial hemorrhage
between 6 and 48 h (Fig. 4C–E).
To investigate a possible direct myotoxic effect of the
LOBE, an isolated muscle preparation was used. As shown
in Fig. 5A, when two different concentrations of the LOBE
were added to the extensor digitorum longus (EDL) prepa-
rations, dose- and time-dependent increases in CK release
rates were observed in comparison to the controls (EDL
treated with PBS). This result indicated that the venom has
speciﬁc myotoxins that are able to act directly on muscle
cells, which conﬁrms the data obtained systemically in
envenomed rats. When compared with the snake venom
from B. jararaca (a well characterizedmyotoxic venom), the
LOBE presented a myotoxic activity that was approximately
32.6% lower at the same dose (Fig. 5B). In addition, the
previous incubation of the LOBE with antilonomic serum
(ALS) resulted in a reduction of 70.6% in CK release rate
from the EDL. The highest level of released CK was
observed upon the addition of the cytotoxic compound
Triton X-100 (0.01%), which was used as a non-speciﬁc,
non-biological positive control. Taking the muscle injury
induced by Triton X-100 to be 100%, the myotoxic damage
of the B. jararaca and L. obliqua venoms reached 58.8% and
39.6%, respectively, in our experimental conditions.
3.5. Genotoxicity
Because themaintenanceof genomic stability is essential
for cellular function, we measured the genotoxic effects
induced by L. obliqua experimental envenomation in vivo
(Fig. 6). In the ﬁrst set of experiments, DNA damage in the
different organs and lymphocytes of rats 12 h after LOBE
injection (1 mg/kg, s.c.) was assessed using the alkalinecomet assay. For all samples, cell viability was evaluated
using the trypanblue exclusionmethod andwas found to be
greater than 90% in every experiment. The internal controls
for the comet assay, using human blood cells, showed low
damage in thenegative control (DI¼0–10) andhighdamage
in the positive control (DI ¼ 180–300), thus validating the
test conditions. As expected, exposure of the lymphocytes,
heart, lungs, liver and kidney cells that had been isolated
from normal animals to methyl methanesulfonate (MMS),
which was used as positive control, resulted in a signiﬁcant
increase in DNA damage (not shown). As shown in Fig. 6A,
envenomed rats displayed high levels of DNAdamage in the
cells of all organs evaluated, as well as in the lymphocytes.
The damage levels in the cells of the control animals (those
that had been injected with PBS) did not change signiﬁ-
cantly. The damage index in lymphocytes and kidneys
reached levels that were 6.4 and 5.4 times higher than the
levels in their respective controls.
In another set of experiments, the kidneys were chosen
to determine the temporal pattern of DNA damage at
distinct time points after LOBE injection. In such cases,
kidneys were selected because they had the highest dam-
age index among the organs examined and also due to the
high incidence of renal injury observed in human patients
(Gamborgi et al., 2006). At 6 h, kidney DNA damage had
increased, reaching a maximal level at 12 h. After 48 h, the
damage index decreased but was still signiﬁcantly different
from the controls (Fig. 6B). In order to verify the oxidative
nature of the DNA damage detected in the kidney cells of
LOBE-injected rats, we carried out a modiﬁed comet assay.
While the alkaline test normally detects primarily repair-
able DNA single- and double-strand breaks and alkali-labile
sites, the modiﬁed version is more speciﬁc to oxidative
damage than the standard method. The modiﬁed version
includes an incubation step with lesion-speciﬁc endonu-
cleases that recognize resultant abasic sites and convert
them into single-strand breaks. In the present study, we
Fig. 2. Light micrographs showing the histopathological changes induced by L. obliqua venom in the vital organs of rats. A. Skin, 6 h post-envenomation, pre-
senting subcutaneous hemorrhage at the site of venom injection (arrowheads). B. Skin, 12 h post-envenomation. Note the skeletal muscle necrosis (N) and
inﬂammatory inﬁltrate (white asterisk). C. Kidney, 6 h post-envenomation. Cortical sections showing the deposits of a red-brown material in the tubules forming
granular casts (arrows). Insert: Detail of an intra-tubular cast. D. Kidney, 48 h post-envenomation. Medullar section evidencing inﬂammatory inﬁltrate (white
asterisk). Insert: Cortical section showing tubules with hyaline casts (arrows). E. Spleen, 6 h post-envenomation. Note the marked diffuse congestion and
erythrophagocytosis. Insert: Detail of erythrophagocytosis (arrowhead). F. Spleen, 48 h post-envenomation. Note the large aggregates of hemosiderin engulfed
macrophages (arrowheads). All sections were stained with H&E. Magniﬁcations: 10 (Panels A, C, D, inserts in D and E); 40 (Panels B, inserts in C, E and F).
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III, which targets oxidized pyrimidines. Thus, increases in
the damage index after enzyme incubation speciﬁcally
represent the extent of oxidative DNA damage. As shown in
Fig. 6C and D, there was an increase in the oxidative
damage score after incubation with Fpg and Endo III,
indicating the presence of oxidized purines and pyrimi-
dines. As the levels of ordinary and oxidatively generated
DNA adducts were similar (mainly between 6 and 12 h), the
majority of the DNA damage observed in the kidneys was
likely due to oxidative insult (Fig. 6B–D).
3.6. Effects of antivenom treatment on markers of systemic
tissue damage
Since the administration of antilonomic serum (ALS) is
the only speciﬁc treatment actually available for L. obliqua
envenomation, we decided to test its efﬁcacy inneutralizing biochemical and coagulation abnormalities
using our experimental model. For this purpose, ALS was
intravenously administered at 2 or 6 h post-LOBE injection
(1 mg/kg, s.c.). After 24 h of envenomation, different
biochemical markers and coagulation parameters were
determined (Table 3). Generally, treatment with ALS is able
to neutralize LOBE-induced biochemical alterations only if
administered within the ﬁrst 2 h of envenomation. For
example, animals treated with ALS at 2 h had a decrease of
3.6- and 2.5-fold in the levels of serum creatinine and urea,
respectively, when compared with the group treated 6 h
after LOBE injection. In addition, both the creatinine and
urea levels of the envenomed animals that had been
treated at 2 h with ALS were not signiﬁcantly different from
the values observed in non-envenomed rats that had been
treated with PBS or ALS, indicating that these levels had
returned to control values. Similar results were obtained
for other parameters, such as CK, CK-MB, AST and ALT,
Fig. 3. Light micrographs showing the histopathological changes in the
lungs of rats that had been injected with L. obliqua venom. Section of the
lungs from envenomed animals presented extensive hemorrhage mainly 6 h
post-venom injection (A), signs of inﬂammation such as edema (B) and
perivascular edema (insert in B) at 12 h, and inﬂammatory cell inﬁltrate (C)
at 48 h. All sections were stained with H&E. Asterisks and arrowheads in
panel B indicate areas of edema and perivascular edema, respectively.
Magniﬁcation: 10 (Panels A–C).
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received ALS within the ﬁrst 2 h. Likewise, plasma hemo-
globin levels were also decreased in envenomed rats when
ALS was injected at 2 h. However, this reduction was not
statistically signiﬁcant in comparison to envenomed ani-
mals that had been treated with PBS instead of ALS. Thus,
ALS was not able to completely reverse intravascular he-
molysis, even if given early after envenomation.
As expected, envenomed animals that were treatedwith
PBS developed consumptive coagulopathy, with lower
levels of ﬁbrinogen and prolonged activated partial
thromboplastin time (Table 3). In this case, the treatment
with ALS both at 2 or 6 h after venom injection normalized
the coagulation parameters. The macroscopic andhistological signs of hemorrhage were also absent in the
envenomed groups that had received ALS injections at 2 or
6 h (results not shown).
4. Discussion
In the present study, we used an experimental model in
rats to investigate the acute physiopathological effects of L.
obliqua venom. This model allowed for the broad charac-
terization of venom-induced tissue damage, including
biochemical, hematological, histopathological, myotoxic,
cardiotoxic and genotoxic alterations.
Envenomed animals showed macroscopic and histo-
logical evidence of systemic hemorrhages, conﬁrming the
main clinical proﬁle observed in human patients (Zannin
et al., 2003). Bleeding in the abdominal cavity and subcu-
taneous tissue, hematuria and hemorrhages in the
myocardium and pulmonary parenchymawere observed in
our experimental animals. Actually it is known that
different venom toxins are involved in these hemorrhagic
alterations. Most of the toxins are serine proteases, an
expressive group representing 16.7% and 25% of the clusters
derived from the tegument and bristle transcriptomes,
respectively (Veiga et al., 2005). This protein group displays
coagulation factor-like activities, so these enzymes are ex-
pected to participate in the generation of thrombin by
activation of factor X and prothrombin (Veiga et al., 2009;
Berger et al., 2010a) and in the activation of the ﬁbrino-
lytic system, contributing directly and indirectly to ﬁbrin-
ogen degradation (Pinto et al., 2006), resulting in
consumption coagulopathy. In fact, serine proteases with
ﬁbrinogenolytic, prothrombin and factor X activating ac-
tivities have been puriﬁed and characterized in this venom
(Alvarez-Flores et al., 2006; Pinto et al., 2004; Reis et al.,
2006). Rats injected intravenously with one of these en-
zymes, a puriﬁed prothrombin activator, displayed coa-
gulopathy that was associated with reduced levels of
ﬁbrinogen, pulmonary hemorrhage and leukocyte inﬁltra-
tion in the lungs (Reis et al., 2001), which was similar to the
observations presented here for whole venom.
In addition to the hemostatic abnormalities, the rats
displayed intravascular hemolysis, as evidenced by alter-
ations in several parameters, such as high levels of free
hemoglobin, increased unconjugated bilirubin levels, high
serum LDH activity, decreased RBC counts and hematocrit,
and the presence of reticulocytes (immature RBCs), spher-
ocytes and fragmented RBCs in the blood smears. The
spleens of the envenomed animals also presented signs of
erythrophagocytosis and deposits of hemosiderin, indi-
cating high clearance of defective RBCs and the accumu-
lation of hemoglobin metabolic products. An important
contribution of this hemolytic process to venom-induced
pathology is most likely related to the deposition of he-
moglobin in the renal tubules. Hemolysis-related AKI is
characterized by the formation of tubular hemoglobin
casts, which are highly nephrotoxic (Zager, 1996). In the
present study, envenomed animals presented red-brown
and hyaline pigments with a granular appearance in their
renal tubules which were most likely due to the formation
of hemoglobin and/or myoglobin deposits. Reports
describing a human case of hemolysis-related AKI, and also
Fig. 4. In vivo myotoxic and cardiotoxic activities. Serum levels of creatine kinase (A) and creatine kinase-MB (B) during the time-course of L. obliqua enven-
omation in rats. Histopathological analyses of the heart conﬁrmed the cardiotoxicity of the venom. At 6 h of envenomation, there were extensive areas of
myocardial hemorrhage (C). Necrosis of cardiomyocytes (D) and inﬂammation (E) were observed mainly at 12 and 48 h, respectively. These alterations are shown
in detail in the insert of each image. Arrowheads in panel D indicate necrotic cells. All sections were stained with H&E. Magniﬁcations: 10 (Panels C, D and E);
20 (Insert in C); 40 (Inserts in D and E). Biochemical data are presented as the means  SE. Each sample from the control (CTRL, n ¼ 6, injected with PBS, s.c.)
or envenomed animals (n ¼ 8, injected with LOBE, 1 mg/kg, s.c.) was measured in triplicate. Values of p < 0.001 were considered to be signiﬁcantly different from
the controls.
Fig. 5. In vitro myotoxic activity. The effects of L. obliqua venom were tested
on isolated EDL muscles. A. At time ¼ 0, PBS (control, CTRL) or different
concentrations of LOBE were added to the perfusion bath containing the EDL
muscles. Aliquots were taken at the indicated times to determine creatine
kinase (CK) levels. Each time point represents the means  SE of six inde-
pendent experiments. The levels of CK that were released from EDL previ-
ously treated with LOBE differed from the controls at all time points
(p < 0.05). B. The myotoxic activity of LOBE was also compared in the
presence or absence of antilonomic serum (ALS). Bothrops jararaca venom
(BjV) and Triton X-100 (0.01%) were used as positive controls for myotoxic
activity. After 120 min, aliquots were taken for the CK determinations. Data
are expressed as the means  SE (n ¼ 6/group). Values of p < 0.05 were
considered to be statistically signiﬁcant for the comparisons among the
groups.
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intravascular hemolysis, have already been published
(Seibert et al., 2004; Malaque et al., 2006). However, little is
known regarding the ability of ALS to neutralize hemolytic
effects. Our data indicate that ALS was not able to
completely reverse intravascular hemolysis, even if
administered early in the envenomation. The case report of
hemolysis-related AKI also indicated that treatment with
ALS did not reduce hemoglobin levels to normal values and
the patient did not completely recover renal function until
1 month after the accident, despite improvements in
coagulation tests (Malaque et al., 2006). Until now, the
main component with high in vitro hemolytic activity iso-
lated from this venom was the phospholipase A2 enzyme,
although the presence of proteolytic enzymes that act
speciﬁcally on the membrane glycoproteins of erythrocytes
cannot be ruled out (Seibert et al., 2006, 2010).
Since myotoxins are commonly described in several
snake, spider and bee venoms, the presence of myotoxic
activity in L. obliqua was investigated using speciﬁc
biochemical markers, in vitro experiments and histological
analyses. In this sense, elevations of serum CK and CK-MB
activities were detected, indicating systemic damage to
skeletal and cardiac muscles. CK is a dimer with M and B
subunits that is found primarily in themuscle, myocardium,
brain and lung tissues and exists as three dimeric iso-
enzymes: CK-MM, CK-MB and CK-BB. CK-MB accounts for
5%–50% of total CK activity in the myocardium and is well-
established to be a clinical marker that can conﬁrm acute
myocardial infarction both in humans and experimental
animals (Apple and Preese, 1994; Shashidharamurthy et al.,
Fig. 6. Genotoxic activity. A. DNA damage in the different organs of the control (CTRL, injected with PBS, s.c.) and envenomed animals (injected with the LOBE,
1 mg/kg, s.c.) was assessed using the alkaline comet assay 12 h post-venom injection. B. The temporal pattern of DNA damage in the kidneys of the control and
envenomed animals at different time points. C and D. Oxidative DNA damage in the kidneys was also determined at different times post-venom administration
using the modiﬁed version of the comet assay with Fpg (C) and Endo III (D) enzymes. Data are expressed as the means  SE (n ¼ 6 rats/group). Values of p < 0.05
and p < 0.001 (*) were considered to be statistically signiﬁcant in comparison to the control groups.
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tological analyses revealed extensive muscle damage
mainly in the subcutaneous tissue (at the local site of venom
injection) and myocardial necrosis. These observations
support the idea that the LOBE has cardiotoxic activity,
whichwasunknownupuntil now. Clinical reports of human
envenomation that are available in the literature do not
describe symptoms of cardiac dysfunction, and CKor CK-MB
levels are rarely measured in these patients, making it
difﬁcult to make any comparisons with our experimental
data. Our hypothesis is that the contribution of muscle
damage observed herein is more related to myoglobin
release from the myocytes or cardiomyocytes than to a
mechanism that is associated with heart dysfunction.
Indeed, similar to hemoglobin, myoglobin can also precipi-
tate in renal tubules, after being ﬁltered by the glomeruli,
and forms obstructive casts. The direct myotoxic activity of
LOBE was conﬁrmed in vitro by the experiments with iso-
lated EDL muscles. LOBE showed a dose- and time-
dependent myotoxicity in isolated EDL, although its po-
tency was lower when compared to B. jararaca venom. In
fact, different myotoxins have been described in B. jararaca
venom, including metalloproteinases and myotoxicphospholipaseA2 (Zelanis et al., 2011),while in L. obliqua the
toxins responsible for this activity remain completely un-
known. However, L. obliqua myotoxins seem to be recog-
nized by ALS because treatmentwith this serumwas able to
reverse CK release in vitro (from EDL muscle) and in vivo if
administered within 2 h of envenomation.
Though AKI is the leading cause of death following L.
obliqua envenomation, the mechanisms involved in kidney
disorders are poorly understood (Gamborgi et al., 2006).
The current knowledge is based on clinical data from
human victims in which hematuria, high levels of serum
creatinine and acute tubular necrosis were described to be
the main features of L. obliqua-induced AKI (Burdmann
et al., 1996). In our experimental model, in addition to the
high levels of serum creatinine, the rats also displayed
uremia and hyperuricemia, suggesting impaired renal
function. Generally, the mechanism underlying venom-
induced AKI is complex and appears to be multifactorial.
Until now, studies performed with a variety of nephrotoxic
venoms have indicated that AKI is associated with both the
direct cytotoxic action of the venom on renal structures and
a secondary response of the whole organism resulting from
systemic envenomation (Abdulkader et al., 2008; Berger
Table 3
Effects of treatment with anti-lonomic serum (ALS) on markers of systemic tissue damage during L. obliqua envenomation.
Treatment group Cr (mg/dL) BUN (mg/dL) CK (U/L) CK-MB (U/L) Hb (mg/dL) AST (U/mL) ALT (U/mL) FBG (g/L) aPTT (s)
PBS 0.3  0.04 67.1  2.9 16.7  1.1 6.0  0.5 65.2  5.1 16.5  1.6 14.9  2.1 1.6  0.04 31.7  3.8
ALS 0.3  0.07b,c 65.5  3.7b,c 18.9  1.5b,c 5.3  0.4b,c 62.2  2.3c 36.3  3.1b,c 42.1  1.9a,b,c 2.1  0.4b 32.7  2.8
LOBE þ PBS 1.9  0.2a 175.3  18.8a 244.2  26.6a 54.3  7.1a 215.6  72.6a 106.7  20.8a 72.1  5.1a 0.5  0.04a 79.9  17a
LOBE þ ALS (2 h) 0.5  0.05b,c 53.2  2.0b,c 32.9  4.7b,c 5.8  0.8b,c 137.4  19.8 30.3  1.0b,c 26.3  1.7b,c 2.3  0.3b 22.5  1.5b
LOBE þ ALS (6 h) 1.8  0.2a 133.3  4.6a,b 278.9  25.5a 41.1  5.1a,b 271.1  53.9a 90.9  5.9a 67.0  6.3a 1.6  0.2b 36.4  5.6b
Cr: creatinine; BUN: blood urea nitrogen; CK: creatine kinase; CK-MB: creatine kinase isoenzyme MB; Hb: plasma hemoglobin; AST: aspartate amino-
transferase; ALT: alanine aminotransferase; FBG: ﬁbrinogen; aPTT: activated partial thromboplastin time. Envenomed animals (n ¼ 8/group) were treated
with PBS or ALS after 2 or 6 h of LOBE injection (1 mg/kg, via s.c). Control animals (n ¼ 6/group) were injected only with PBS or ALS. After 24 h, samples of
plasma and serum were collected. Data are presented as means  SE. Statistical analyses were performed by ANOVA followed by Bonferroni’s post hoc test.
a(p < 0.05 vs PBS), b(p < 0.05 vs LOBE þ PBS) and c(p < 0.05 vs LOBE þ ALS 6 h).
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renal inﬂammation, oxidative damage and the release of
cytokines and vasoactive substances that lead to changes in
renal function and hemodynamics. Hemolysis, rhabdo-
myolysis and/or the intravascular deposition of platelets
and ﬁbrin in the kidneymicrocirculation are also important
contributors to this process (Sitprija, 2006). Recently, high
levels of uric acid were observed to play an important role
in AKI induced by Crotalus envenomation, since the treat-
ment with allopurinol, a hypouricemiant agent, signiﬁ-
cantly reduced the lethality rate and ameliorated renal
histopathological changes (Frezzatti and Silveira, 2011).
Marked hyperuricemia is known to cause AKI by the su-
persaturation, crystallization and deposition of urate crys-
tals, as well as by contributing to renal vasoconstriction,
since soluble uric acid has been shown to inhibit endo-
thelial NO bioavailability (Yamasaki et al., 2008; Ejaz et al.,
2007). During L. obliqua envenomation, the rats also pre-
sented high levels of uric acid, tubular obstructive casts and
inﬂammatory inﬁltrates in the kidneys. However, the actual
contribution of these elements to AKI requires further
study. Interestingly, antivenom serotherapy was able to
reduce creatinine and urea levels only if administered
within 2 h of LOBE injection. Antivenom treatment after 6 h
was unable to fully correct the renal parameters, despite its
ability to normalize coagulation abnormalities. Thus, it
seems that the time elapsed between the accident and the
administration of antivenom is crucial for a successful renal
therapy. Conﬁrming our observations, it was demonstrated
that a time interval of more than 2 h between the accident
and administration of the antivenom was associated with
the development of AKI, as well as with the risk of death or
permanent injuries after Bothrops and Crotalus envenom-
ation (Otero et al., 2002; Pinho et al., 2005).
Unlike the lungs, kidneys, spleens and hearts, no
morphological changes were observed in the livers, brains
and cerebellums of rats that had been injected with L.
obliqua venom. Nevertheless, biochemical markers of acute
liver injury (AST, ALT and g-GT) were increased in the
serum of animals after envenomation. As it is known that
some of these enzymes are not speciﬁc to the liver, it is
possible that they were derived from other sources, such as
the red blood cells or skeletal muscle. For instance, in-
creases in AST activity are also associated with damage to
cardiac and skeletal muscle and the kidneys (Prado et al.,
2010; Shashidharamurthy et al., 2010). Despite these
apparently conﬂicting observations, we cannot rule out theoccurrence of liver injury, mainly because evidence of DNA
damage was detected in liver cells using the comet assay.
Probably, these ﬁndings indicate that the extent of acute
hepatic injury in this model of envenomation was subtle
and did not lead to gross histological alterations.
As mentioned above, L. obliqua envenomation may have
triggered an intense inﬂammatory response, which may be
involved in several of the clinical manifestations. The acti-
vation of the kallikrein-kinin system and the consequent
release of vasoactive mediators (mainly bradykinin, hista-
mine and prostaglandins) seems to play an essential role in
the edematogenic, nociceptive and vascular effects (Bohrer
et al., 2007). Accordingly, we have shown that during en-
venomation the animals experienced neutrophilic leuko-
cytosis, indicating that a systemic inﬂammatory response
had occurred. Histological sections also provided evidence
of inﬂammatory cell inﬁltrates in the heart, lungs and
kidneys. Corroborating these results, a clear activation in
the vascular bed that was characterized by an increase in
leukocyte rolling and adhesion to the endothelium was
observed in hamster cheek pouch venules that had previ-
ously been incubated with low doses of LOBE (Nascimento-
Silva et al., 2012). The up-regulated expression of genes
from pro-inﬂammatorymediators and adhesionmolecules,
such as IL-8, IL-6, CCL2, CXCL1, E-selectin, VCAM-1 and
ICAM-3, was also detected in endothelial cells and ﬁbro-
blasts after incubation with LOBE. Once released, these
mediators acted as chemoattractants, inducing inﬂamma-
tory cell migration to the sites of injury (Pinto et al., 2008;
Nascimento-Silva et al., 2012).
Recently, classical methods of genetic toxicology have
been applied to the identiﬁcation of potential therapeutic
agents in animal venoms (mainly for the treatment of some
types of cancer) and have also provided a better under-
standing of the toxic mechanisms of action of these venoms
in the human body (Marcussi et al., 2011, 2013). During
envenomation, genotoxic damage can occur directly due to
the cytotoxic activity of the venom or indirectly through
the production of cytotoxic mediators (such as free radicals,
for example) in response to tissue injury. In both cases, the
damage could lead to DNA fragmentation and eventually,
cell death. In the case of cell survival, DNA lesions not
corrected during the cell repair process might result in
permanent mutations and changes to cellular morphology
or physiology that could also be transmitted hereditarily to
future generations. Therefore, it is possible that the geno-
toxic effects are involved not only in the acute toxicity, but
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mutagenic and carcinogenic events resulting from enven-
omation. In this sense, it has been shown that some
Bothrops toxins are able to induce genotoxic andmutagenic
effects in isolated human lymphocytes, as evidenced by the
comet and micronucleus assays, respectively (Marcussi
et al., 2013). Here, various organs of animals that had
been injectedwith L. obliqua venom presented DNA lesions,
indicating the high genotoxic potential of this venom. DNA
damage was detected in the kidneys, heart, lungs, liver and
lymphocytes of envenomed rats. Speciﬁcally, DNA lesions
in the kidneys were prominent 6, 12 and 48 h post-
envenomation, and the majority of these lesions were
due to oxidative damage because oxidized purines and
pyrimidines were detected. In fact, the possible production
of free radicals during envenomation should be considered
in an effort to understand the complex mechanisms
involved in kidney dysfunction. In this case, the presence of
hemoglobin and/or myoglobin deposits in the renal tubules
may contribute to kidney dysfunction, since the degrada-
tion of these molecules releases free iron and heme, which
catalyze the production of free radicals and induce lipid
peroxidation, respectively (Zager, 1996; Yamasaki et al.,
2008). The participation of oxidative damage was
conﬁrmed in a model of Crotalus-induced AKI, in which
treatment with antioxidant agents protects against venom-
mediated nephrotoxicity (Alegre et al., 2010).
5. Conclusions
In this work, we characterized a series of acute physio-
pathological effects induced by the subcutaneous injection
of L. obliqua venom in rats. Our data reveal important
biochemical, hematological and histopathological alter-
ations, suggesting the occurrence of multi-organ damage
and conﬁrming that the rat is a good animal model for
studying hemorrhagic disturbances, as well as organ spe-
ciﬁc injuries, such as AKI. Interestingly, myotoxic, car-
diotoxic and genotoxic activities were identiﬁed during our
experiments. To our knowledge, this is the ﬁrst study to
show these activities of L. obliqua venom. Finally, the
ﬁndings presented here emphasize the fact that a correct
diagnosis and early treatment is essential for successful
antivenom serotherapy, since the efﬁcacy of serotherapy in
neutralizing the physiopathological alterations is only
observed if serotherapy is administered during the initial
phase of envenomation.Acknowledgments
We would like to thank Dr. Carlos Termignoni (Departa-
mento de Bioquímica e Centro de Biotecnologia – Uni-
versidade FederaldoRioGrandedoSul) forhis critical review
of themanuscript.Weare also indebted toMrs. ZelmaRegina
de Almeida for her animal handling. This work was sup-
ported by funding and fellowships from the Brazilian
Agencies: Coordenação de Aperfeiçoamento de Pessoal de
Nível Superior, Ministério da Educação, Brazil (CAPES-MEC)
– Edital Toxinologia (Processo: 23038.006277/2011-85)
and Conselho Nacional de Desenvolvimento Cientíﬁco eTecnológico, Ministério da Ciência e Tecnologia, Brazil
(CNPq-MCT).
Conﬂict of interest statement
The authors declare that there are no conﬂicts of
interest.References
Abdulkader, R.C., Barbaro, K.C., Barros, E.J., Burdmann, E.A., 2008. Neph-
rotoxicity of insect and spider venoms in Latin America. Semin.
Nephrol. 28 (4), 373–382.
Alegre, V.S., Barone, J.M., Yamasaki, S.C., Zambotti-Villela, L., Silveira, P.F.,
2010. Lipoic acid effects on renal function, aminopeptidase activities
and oxidative stress in Crotalus durissus terriﬁcus envenomation in
mice. Toxicon 56 (3), 402–410.
Alvarez-Flores, M.P., Fritzen, M., Reis, C.V., Chudzinski-Tavassi, A.M., 2006.
Losac, a factor X activator from Lonomia obliqua bristle extract: its role
in the pathophysiological mechanisms and cell survival. Biochem.
Biophys. Res. Commun. 343, 1216–1223.
Apple, F.S., Preese, L.M., 1994. Creatine kinase-MB: detection of myocar-
dial infarction and monitoring reperfusion. J. Clin. Immunoass. 17, 24–
29.
Arocha-Piñango, C.L., Marval, E., Guerrero, B., 2000. Lonomia genus
caterpillar toxins: biochemical aspects. Biochimie 82, 937–942.
Azqueta, A., Shaposhnikov, S., Collins, A.R., 2009. DNA oxidation: inves-
tigating its key role in environmental mutagenesis with the comet
assay. Mutat. Res. 674 (1–2), 101–108.
Berger, M., Reck Jr., J., Terra, R.M., Pinto, A.F., Termignoni, C.,
Guimarães, J.A., 2010a. Lonomia obliqua caterpillar envenomation
causes platelet hypoaggregation and blood incoagulability in rats.
Toxicon 55 (1), 33–44.
Berger, M., Reck Jr., J., Terra, R.M., Beys da Silva, W.O., Santi, L., Pinto, A.F.,
Vainstein, M.H., Termignoni, C., Guimarães, J.A., 2010b. Lonomia
obliqua venomous secretion induces human platelet adhesion and
aggregation. J. Thromb. Thrombolysis 30 (3), 300–310.
Berger, M., Vieira, M.A.R., Guimaraes, J.A., 2012. Acute kidney injury
induced by snake and arthropod venoms. In: Polenakovic, M. (Ed.),
Renal Failure – the Facts. InTech-Open, Rijeka, Croatia, ISBN 978953-
51-0630-2, pp. 157–186.
Bohrer, C.B., Reck Jr., J., Fernandes, D., Sordi, R., Guimarães, J.A., Assreuy, J.,
Termignoni, C., 2007. Kallikrein-kinin system activation by Lonomia
obliqua caterpillar bristles: involvement in edema and hypotension
responses to envenomation. Toxicon 49, 663–669.
Burdmann, E.A., Antunes, I., Saldanha, L.B., Abdulkader, R.C., 1996. Severe
acute renal failure induced by the venom of Lonomia caterpillars. Clin.
Nephrology 46 (5), 337–339.
Burlinson, B., Tice, R.R., Speit, G., Agurell, E., Brendler-Schwaab, S.Y.,
Collins, A.R., Escobar, P., Honma, M., Kumaravel, T.S., Nakajima, M.,
Sasaki, Y.F., Thybaud, V., Uno, Y., Vasquez, M., Hartmann, A., 2007.
Fourth international workgroup on genotoxicity testing: results of the
in vivo Comet assay workgroup. Mutat. Res. 627, 31–35.
Caovilla, J.J., Barros, E.J., 2004. Efﬁcacy of two different doses of anti-
lonomic serum in the resolution of hemorrhagic syndrome resulting
from envenoming by Lonomia obliqua caterpillars: a randomized
controlled trial. Toxicon 43, 811–818.
Da Silva, G.H., Hyslop, S., Cruz-Höﬂing, M.A., 2004a. Lonomia obliqua
caterpillar venom increases permeability of the blood–brain barrier
in rats. Toxicon 44, 625–634.
Da Silva, G.H., Panunto, P.C., Hyslop, S., Da Cruz-Höﬂing, M.A., 2004b.
Immunochemical detection of Lonomia obliqua caterpillar venom in
rats. Microsc. Res. Tech. 65, 276–281.
De Castro Bastos, L., Veiga, A.B., Guimarães, J.A., Tonussi, C.R., 2004.
Nociceptive and edematogenic responses elicited by a crude bristle
extract of Lonomia obliqua caterpillars. Toxicon 43, 273–278.
Dias da Silva, W., Campos, C.M., Gonçalves, L.R., Sousa-e-Silva, M.C.,
Higashi, H.G., Yamagushi, I.K., Kelen, E.M., 1996. Development of an
antivenom against toxins of Lonomia obliqua caterpillars. Toxicon 34,
1045–1049.
Ejaz, A.A., Mu, W., Kang, D.H., Roncal, C., Sautin, Y.Y., Henderson, G.,
Tabah-Fisch, I., Keller, B., Beaver, T.M., Nakagawa, T., Johnson, R.J.,
2007. Could uric acid have a role in acute renal failure. Clin. J. Am. Soc.
Nephrol. 2 (1), 16–21.
Frezzatti, R., Silveira, P.F., 2011. Allopurinol reduces the lethality associ-
ated with acute renal failure induced by Crotalus durissus terriﬁcus
M. Berger et al. / Toxicon 74 (2013) 179–192192snake venom: comparison with probenecid. PLoS Negl. Trop. Dis. 5
(9), e1312.
Fuly, A.L., Calil-Elias, S., Martinez, A.M., Melo, P.A., Guimarães, J.A., 2003.
Myotoxicity induced by an acidic Asp-49 phospholipase A(2) isolated
from Lachesis muta snake venom. Comparison with lysophosphati-
dylcholine. Int. J. Biochem. Cell Biol. 35 (10), 1470–1481.
Gamborgi, G.P., Metcalf, E.B., Barros, E.J.G., 2006. Acute renal failure
provoked by toxin from caterpillars of the species Lonomia obliqua.
Toxicon 47, 68–74.
Garcia, C.M., Danni-Oliveira, I.M., 2007. Occurrence of accidents caused by
Lonomia obliqua Walker, in state of Paraná between 1989 and 2001.
Rev. Soc. Bras. Med. Trop. 40, 242–246.
Gonçalves, L.R., Sousa-e-Silva, M.C., Tomy, S.C., Sano-Martins, I.S., 2007.
Efﬁcacy of serum therapy on the treatment of rats experimentally
envenomed by bristle extract of the caterpillar Lonomia obliqua:
comparison with epsilon-aminocaproic acid therapy. Toxicon 50,
349–356.
Greggio, S., Rosa, R.M., Dolganov, A., de Oliveira, I.M., Menegat, F.D.,
Henriques, J.A.P., Da Costa, J.C., 2009. NAP prevents hippocampal
oxidative damage in neonatal rats subjected to hypoxia-induced
seizures. Neurobiol. Dis. 36, 435–444.
Guimarães, J.A., 2011. Toxinas: Envenenamento por animais peçonhentos.
Situação no Brasil. In: de Souza, W. (Ed.), Doenças Negligenciadas.
Academia Brasileira de Ciências – Ciência e Tecnologia para o
Desenvolvimento – Estudos Estratégicos, Rio de Janeiro, Brazil,
pp. 34–38.
Hossler, E.W., 2010. Caterpillars and moths: part II. Dermatologic mani-
festations of encounters with Lepidoptera. J. Am. Acad. Dermatol. 62
(1), 13–28.
Kowacs, P.A., Cardoso, J., Entres, M., Novak, E.M., Werneck, L.C., 2006. Fatal
intracerebral hemorrhage secondary to Lonomia obliqua caterpillar
envenoming, a case report. Arq. Neuropsiquiatr. 64, 1030–1032.
Malaque, C.M.S., Andrade, L., Madalosso, G., Tomy, S., Tavares, F.L.,
Seguro, A.C., 2006. Short report: a case of hemolysis resulting from
contact with a Lonomia caterpillar in southern Brazil. Am. J. Trop.
Med. Hyg. 74, 807–809.
Marcussi, S., Santos, P.R., Menaldo, D.L., Silveira, L.B., Santos-Filho, N.A.,
Mazzi, M.V., da Silva, S.L., Stábeli, R.G., Antunes, L.M., Soares, A.M.,
2011. Evaluation of the genotoxicity of Crotalus durissus terriﬁcus
snake venom and its isolated toxins on human lymphocytes. Mutat.
Res. 724 (1–2), 59–63.
Marcussi, S., Stábeli, R.G., Santos-Filho,N.A.,Menaldo,D.L., Silva Pereira, L.L.,
Zuliani, J.P., Calderon, L.A., da Silva, S.L., Greggi Antunes, L.M.,
Soares, A.M., 2013. Genotoxic effect of Bothrops snake venoms and
isolated toxins on human lymphocyte DNA. Toxicon 65, 9–14.
Melo, P.A., Suarez-Kurtz, G., 1988. Release of creatine kinase from skeletal
muscles by Bothrops venoms: heparin potentiation of inhibition by
antivenin. Braz. J. Med. Biol. Res. 21 (3), 545–548.
Nadin, S.B., Vargas-Roig, L.M., Ciocca, D.R., 2001. A silver staining method
for single-cell gel assay. J. Histochem. Cytochem. 49, 1183–1186.
Nascimento-Silva, V., Rodrigues da Silva, G., Moraes, J.A., Cyrino, F.Z.,
Seabra, S.H., Bouskela, E., Almeida Guimarães, J., Barja-Fidalgo, C.,
2012. A pro-inﬂammatory proﬁle of endothelial cell in Lonomia
obliqua envenomation. Toxicon 60 (1), 50–60.
Otero, R., Gutiérrez, J., Beatriz-Mesa, M., Duque, E., Rodríguez, O., Luis-
Arango, J., Gómez, F., Toro, A., Cano, F., María-Rodríguez, L., Caro, E.,
Martínez, J., Cornejo, W., Mariano-Gómez, L., Luis-Uribe, F.,
Cárdenas, S., Núñez, V., Díaz, A., 2002. Complications of Bothrops,
Porthidium, and Bothriechis snakebites in Colombia. A clinical and
epidemiological study of 39 cases attended in a university hospital.
Toxicon 40 (8), 1107–1114.
Pinho, F.M., Zanetta, D.M., Burdmann, E.A., 2005. Acute renal failure after
Crotalus durissus snakebite: a prospective survey on 100 patients.
Kidney Int. 67 (2), 659–667.
Pinto, A.F.M., Dobrovolski, R., Veiga, A.B.G., Guimarães, J.A., 2004. Lono-
ﬁbrase, a novel a-ﬁbrinogenase from Lonomia obliqua caterpillars.
Thromb. Res. 113, 147–154.
Pinto, A.F.M., Silva, K.R.L.M., Guimaraes, J.A., 2006. Proteases from Lono-
mia obliqua venomous secretions: comparison of procoagulant,
ﬁbrin(ogen)olytic and amidolytic activities. Toxicon 47, 113–121.
Pinto, A.F.M., Dragulev, B., Guimarães, J.A., Fox, J.W., 2008. Novel per-
spectives in the pathogenesis of Lonomia obliqua caterpillar enven-
omation based on assessment of host response by gene expression
analysis. Toxicon 51, 1119–1128.
Pinto, A.F.M., Berger, M., Reck- Jr., J., Terra, R.M., Guimarães, J.A., 2010.
Lonomia obliqua venom: In vivo effects and molecular aspects asso-
ciated with the hemorrhagic syndrome. Toxicon 56 (7), 1103–1112.Prado, M., Solano-Trejos, G., Lomonte, B., 2010. Acute physiopathological
effects of honeybee (Apis mellifera) envenoming by subcutaneous
route in a mouse model. Toxicon 56 (6), 1007–1017.
Reis, C.V., Farsky, S.H., Fernandes, B.L., Santoro, M.L., Oliva, M.L.,
Mariano, M., Chudzinski-Tavassi, A.M., 2001. In vivo characterization
of Lopap, a prothrombin activator serine protease from the Lonomia
obliqua caterpillar venom. Thromb. Res. 102 (5), 437–443.
Reis, C.V., Andrade, S.A., Ramos, O.H., Ramos, C.R., Ho, P.L., Batista, I.F.,
Chudzinski-Tavassi, A.M., 2006. Lopap, a prothrombin activator from
Lonomia obliqua belonging to the lipocalin family: recombinant pro-
duction, biochemical characterization and structure–function in-
sights. Biochem. J. 398 (2), 295–302.
Ricci-Silva, M.E., Valente, R.H., León, I.R., Tambourgi, D.V., Ramos, O.H.,
Perales, J., Chudzinski-Tavassi, A.M., 2008. Immunochemical and
proteomic technologies as tools for unravelling toxins involved in
envenoming by accidental contact with Lonomia obliqua caterpillars.
Toxicon 51, 1017–1028.
Rocha-Campos, A.C., Gonçalves, L.R., Higasshi, H.G., Yamagushi, I.K.,
Fernandes, I., Oliveira, J.E., Ribela, M.T., Sousa-e-Silva, M.C., Dias da
Silva, W., 2001. Speciﬁc heterologous F(ab0)2 antibodies revert blood
incoagulability resulting from envenoming by Lonomia obliqua cat-
erpillars. Am. J. Trop. Med. Hyg. 64, 283–289.
Seibert, C.S., Oliveira, M.R.L., Gonçalves, L.R.C., Santoro, M.L., Sano-
Martins, I.S., 2004. Intravascular hemolysis induced by Lonomia obli-
qua caterpillar bristle extract: an experimental model of envenom-
ation in rats. Toxicon 44, 793–799.
Seibert, C.S., Tanaka-Azevedo, A.M., Santoro, M.L., Mackessy, S.P.,
Torquato, R.J.S., Lebrun, I., Tanaka, A.S., Sano-Martins, I.S., 2006. Pu-
riﬁcation of a phospholipase A2 from Lonomia obliqua caterpillar
bristle extract. Biochem. Biophys. Res. Commun. 342, 1027–1033.
Seibert, C.S., Santoro, M.L., Tambourgi, D.V., Sampaio, S.C., Takahashi, H.K.,
Peres, C.M., Curi, R., Sano-Martins, I.S., 2010. Lonomia obliqua (Lepidop-
tera, Saturniidae) caterpillarbristle extract induces direct lysis bycleaving
erythrocyte membrane glycoproteins. Toxicon 55 (7), 1323–1330.
Singh, N.P., McCoy, M.T., Tice, R.R., Schneider, E.L., 1988. A simple tech-
nique for quantitation of low levels of DNA damage in individual cells.
Exp. Cell Res. 175, 184–191.
Sitprija, V., 2006. Snakebite nephropathy. Nephrology (Carlton) 11 (5),
442–448.
Shashidharamurthy, R., Mahadeswaraswamy, Y.H., Ragupathi, L.,
Vishwanath, B.S., Kemparaju, K., 2010. Systemic pathological effects
induced by cobra (Naja naja) venom from geographically distinct
origins of Indian peninsula. Exp. Toxicol. Pathol. 62 (6), 587–592.
Tice, R.R., Agurell, E., Anderson, D., Burlinson, B., Hartmann, A.,
Kobayashi, H., Miyamae, Y., Rojas, E., Ryu, J.C., Sasaki, Y.F., 2000. Single
cell gel/comet assay: guidelines for in vitro and in vivo genetic toxi-
cology testing. Environ. Mol. Mutagen. 35, 206–221.
Veiga, A.B.G., Blochtein, B., Guimarães, J.A., 2001. Structures involved
production, secretion and injection of the venom produced by the
caterpillar Lonomia obliqua (Lepidoptera, saturniidae). Toxicon 39,
1343–1351.
Veiga, A.B.G., Ribeiro, J.M., Guimarães, J.A., Francischetti, I.M., 2005. A
catalog for the transcripts from the venomous structures of the
caterpillar Lonomia obliqua: identiﬁcation of the proteins potentially
involved in the coagulation disorder and hemorrhagic syndrome.
Gene 355, 11–27.
Veiga, A.B.G., Berger, M., Guimarães, J.A., 2009. Lonomia obliquavenom:
pharmaco-toxicological effects and biotechnological perspectives. In:
De Lima, M.E., Pimenta, A.M., Martin-Eauclaire, M.F., Zingali, R.B.,
Rochat, H. (Eds.), Animal Toxins: the State of the Art. Perspectives on
Health and Biotechnology. Editora da UFMG, Belo Horizonte Brazil,
ISBN 978-85-7041-735-0, pp. 371–390.
Yamasaki, S.C., Villarroel, J.S., Barone, J.M., Zambotti-Villela, L.,
Silveira, P.F., 2008. Aminopeptidase activities, oxidative stress and
renal function in Crotalus durissus terriﬁcus envenomation in mice.
Toxicon 52 (3), 345–354.
Zannin, M., Lourenço, D.M., Motta, G., Costa, L.R.D., Grando, M.,
Gamborgi, G.P., Noguti, M.A., Chudzinski-Tavassi, A.M., 2003. Blood
coagulation and ﬁbrinolytic factors in 105 patients with hemorrhagic
syndrome caused by accidental contactwith Lonomia obliqua caterpillar
in Santa Catarina, Southern Brazil. Thromb. Haemost. 89, 355–364.
Zager, R.A., 1996. Rhabdomyolysis and myohemoglobinuric acute renal
failure. Kidney Int. 49 (2), 314–326.
Zelanis, A., Tashima, A.K., Pinto, A.F., Leme, A.F., Stuginski, D.R.,
Furtado, M.F., Sherman, N.E., Ho, P.L., Fox, J.W., Serrano, S.M., 2011.
Bothrops jararaca venom proteome rearrangement upon neonate to
adult transition. Proteomics 11 (21), 4218–4228.
